» Articles » PMID: 2180758

Bone and Mineral Metabolism in BB Rats with Long-term Diabetes. Decreased Bone Turnover and Osteoporosis

Overview
Journal Diabetes
Specialty Endocrinology
Date 1990 Apr 1
PMID 2180758
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of long-term diabetes mellitus on bone and mineral metabolism was studied in BB rats. Diabetic rats were treated with 1 U of long-acting insulin every other day for 12 wk and compared with nondiabetic littermates. Urinary calcium excretion was increased greater than 10-fold, but serum total and diffusible calcium remained normal. Serum concentrations of both 1 alpha, 25-dihydroxyvitamin D3 and vitamin D-binding protein were significantly decreased in diabetic rats. The intestinal calbindin-D 9K concentration was decreased by nearly 50%, and active duodenal calcium absorption was totally abolished. Trabecular bone volume measured in the tibial metaphysis was decreased by 44%, and the osteoblast and osteoid surfaces were less than 10% of values observed in control rats, whereas the osteoclast surface was unchanged by diabetes. The daily bone formation (bone mineral apposition rate) measured by labeling twice with calcein was decreased by 86% in diabetic rats. The serum concentration of osteocalcin, a biochemical marker of osteoblast function, was similarly decreased (mean +/- SE 23 +/- 3 and 62 +/- 4 micrograms/L in diabetic [n = 15] and nondiabetic [n = 15] rats, respectively). Serum osteocalcin was significantly correlated with the serum concentration of insulinlike growth factor I (r = 0.89, P less than 0.001). Bone strength measured as the energy needed to fracture the femur was markedly decreased (5.3 +/- 1.4 and 8.4 +/- 1.3 N.m.degree in diabetic and nondiabetic rats, respectively; P less than 0.01). These histological, chemical, and biomechanical data clearly indicate that long-standing diabetes in BB rats results in severe low-turnover osteoporosis probably related to decreased osteoblast recruitment and/or function.

Citing Articles

Potential Metabolic Pathways Involved in Osteoporosis and Evaluation of Fracture Risk in Individuals with Diabetes.

Liu T, Wang Y, Qian B, Li P Biomed Res Int. 2024; 2024:6640796.

PMID: 38884020 PMC: 11178402. DOI: 10.1155/2024/6640796.


Hyperbaric oxygen therapy efficacy on mandibular defect regeneration in rats with diabetes mellitus: an animal study.

Eldisoky R, Younes S, Omar S, Gharib H, Tamara T BMC Oral Health. 2023; 23(1):101.

PMID: 36793042 PMC: 9930221. DOI: 10.1186/s12903-023-02801-w.


Associations of insulin resistance and insulin secretion with bone mineral density and osteoporosis in a general population.

Fu Y, Liu W, Lee C, Wang J Front Endocrinol (Lausanne). 2022; 13:971960.

PMID: 36204101 PMC: 9530363. DOI: 10.3389/fendo.2022.971960.


Type 1 diabetes mellitus leads to gingivitis and an early compensatory increase in bone remodeling.

Yuan X, Amin V, Zhu T, Kittaka M, Ueki Y, Bellido T J Periodontol. 2022; 94(2):277-289.

PMID: 35869905 PMC: 9868190. DOI: 10.1002/JPER.22-0192.


Increase in Bone Mass Before Onset of Type 1 Diabetes Mellitus in Rats.

Haralambiev L, Nitsch A, Fischer C, Lange A, Kloting I, Stope M In Vivo. 2022; 36(3):1077-1082.

PMID: 35478116 PMC: 9087105. DOI: 10.21873/invivo.12805.